Another fight over an $87 million mixed-use Canberra development may be on the cards, after the project’s liquidators won approval to assign potential claims against WSP and builder Construction Control over alleged stitch bolt defects.
Pharmacor will be allowed to sell a generic version of heart drug Entresto after the Full Court rejected Swiss drug giant Novartis’ appeal of a ruling that found an extension of the term of its patent for the drug was invalidly granted.
Origin Energy has been ordered to pay a record $17.6 million after admitting it breached Victoria’s energy rules, impacting over 670,000 customers.
A group member in a class action against Johnson & Johnson unit DePuy has filed an appeal after he lost a challenge to his compensation determination, 12 years after the case settled.
A judge recently made the rare decision to declass a representative case, and experts say we may see more of the difficult applications as class actions move into areas with greater variation in the circumstances of group members.
A judge has found that three directors at ASX-listed investment firm Keybridge Capital were validly removed and replaced at a meeting last month.
A judge has refused to vacate a trial next month in a case against a law firm and a barrister by a former client, despite the agreement of all parties to push off the hearing.
Australian building materials giant James Hardie will acquire US-based home decking provider AZEK in a nearly $14 billion merger.
Victoria’s State Revenue Office must pay the bulk of costs incurred by shopping centre landlord Vicinity in a successful challenge to $82.5 million in stamp duty slapped on land occupied by Myer and Emporium in Melbourne’s city centre.
Fortrend Securities has appealed a finding that it breached the Fair Work Act in withholding the bonuses of two financial advisors who jumped to rival Shaw & Partners.